References
1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A.
Global cancer statistics 2018: GLOBOCAN estimates of incidence and
mortality worldwide for 36 cancers in 185 countries. CA Cancer J
Clin 2018;68:394-424.
2. Instituto Nacional de Câncer. Estimativa 2020: incidência de
câncer no Brasil. Rio de Janeiro INCA; 2020.
3. Rowe DE, Carroll RJ, Day CL Jr. Prognostic factors for local
recurrence, metastasis, and survival rates in squamous cell carcinoma of
the skin, ear, and lip. Implications for treatment modality selection.J Am Acad Dermatol. 1992;26(6):976-990.
4. Karia SP, Han J, Schmults CD. Cutaneous Squamous cell carcinoma:
estimated incidence of disease, nodal metastasis, and deaths from
disease in the united states. JAMA Dermatol. 2013;3:957-966.
5. Goh RY, Bova R, Fogarty GB. Cutaneous squamous cell carcinoma
metastatic to parotid - analysis of prognostic factors and treatment
outcome. World J Surg Oncol 2012;25(10):117.
6. Stratigos AJ, Garbe C, Dessinioti C, et al. European
interdisciplinary guideline on invasive squamous cell carcinoma of the
skin: Part 1. epidemiology, diagnostics and prevention. Eur J
Cancer 2020;26(20):30018-30016.
7. Jennings L, Schmults CD. Management of High-Risk Cutaneous Squamous
Cell Carcinoma. J Clin Aesthet Dermatol. 2010;3(4):39-48.
8. Stratigos AJ, Garbe C, Dessinioti C, et al. European
interdisciplinary guideline on invasive squamous cell carcinoma of the
skin: Part 2. Treatment. Eur J Cancer 2020;26(20):30019-30018.
9. Cassarino DS, Derienzo DP, Barr RJ. Cutaneous squamous cell
carcinoma: a comprehensive clinicopathologic classification. Part one.J CutanPathol. 2006;33:191-206.
10. Swenny L, Zimmerman T, Carroll WR, Schmalbach CE, Day KE, Rosenthal
EL. Head and neck cutaneous squamous cell carcinoma requiring
parotidectomy: prognostic indicators and treatment selection.Otolaryngol Head Neck Surg. 2014;150:610-617.
11. Vauterin TJ, Veness MJ, Morgan GJ, Poulsen MG, O’Brien CJ. Patterns
of lymph node spread of cutaneous squamous cell carcinoma of the head
and neck. Head Neck. 2006;28(9):785-791.
12. Bobin C, Ingrand P, Dréno B, Rio E, Malard O, Espitalier F.
Prognostic factors for parotid metastasis of cutaneous squamous cell
carcinoma of the head and neck. European Annals of
Otorhinolaryngology, Head and Neck Diseases,. 2018;135(2):99-103.
13. Gurney B, Newlands C. Management of regional metastatic disease in
head and neck cutaneous malignancy. 1. Cutaneous squamous cell
carcinoma. Br J Oral Maxillofac Surg. 2014;52:294-300.
14. Veness MJ, Palme CE, Morgan GJ. High-risk cutaneous squamous cell
carcinoma of the head and neck: results from 266 treated patients with
metastatic lymph node disease. Cancer 2006;106(11):2389-2396.
15. Lee S, Kim GE, Park CS, et al. Primary squamous cell carcinoma of
the parotid gland. Am J Otolaryngol. 2001;22:400-406.
16. Ch’ng S, Maitra A, Allison RS, et al. Parotid and cervical nodal
status predict prognosis for patients with head and neck metastatic
cutaneous squamous cell carcinoma. J Surg Oncol2008;98(2):101-105.
17. Brantsch KD, Meisner C, Schönfisch B, et al. Analysis of risk
factors determining prognosis of cutaneous squamous-cell carcinoma: a
prospec-tive study. Lancet Oncol. 2008;9:713-720.
18. O’Brien CJ, McNeil EB, McMahon JD, Pathak I, Lauer CS. Incidence of
cervical node involvement in metastatic cutaneous malignancy involving
the parotid gland. Head Neck. 2001;23:744-748.
19. Forest VI, Clark JJ, Veness MJ, Milross C. N1S3: a revised staging
system for head and neck cutaneous squamous cell carcinoma with lymph
node metastases: results of 2 Australian Cancer Centers. Cancer.2010;116(5):1298-1304.
20. Amin MB, Edge S, Greene F, et al. AJCC Cancer Staging Manual
(8th edition). Springer International Publishing: American Joint
Commission on Cancer; 2017; 2017.
21. Thom JJ, Moore EJ, Price DL, Kasperbauer JL, Starkman SJ, Olsen KD.
The Role of Total Parotidectomy for Metastatic Cutaneous Squamous Cell
Carcinoma and Malignant Melanoma. JAMA Otolaryngol Head Neck
Surg. 2014;140(6):548-554.
22. Wei-Chin Chang, Chun-Shu Lin, Cheng-Yu Yang, Chih-Kung Lin, Yuan-Wu
Chen. Lymph node density as a prognostic predictor in patients with
betel nut-related oral squamous cell carcinoma. Clin Oral Invest.2018;22:1513-1521.
23. Agha RA, Borrelli MR, Farwana R, et al. Statement: Updating
Consensus Preferred Reporting Of CasE Series in Surgery (PROCESS)
Guidelines. International Journal of Surgery. 2018;60:279-282.
24. Agha RA, Borrelli MR, Vella-Baldacchino M, Thavayogan R, Orgill DP,
STROCSS Group. The STROCSS statement: Strengthening the Reporting of
Cohort Studies in Surgery. Int J Surg 2017;46:198-202.
25. Ogrinc G, Davies L, Goodman D, Batalden P, Davidoff F, Stevens D.
SQUIRE 2.0 (Standards for QUality Improvement Reporting Excellence):
revised publication guidelines from a detailed consensus process.BMJ Quality & Safety. 2016;25:986-992.
26. National Comprehensive Cancer Network (NCCN). National Comprehensive
Cancer Network (NCCN). NCCN Clinical Practice Guidelines in Oncology.
Squamous Cell Skin Cancer. Version 1.2020. National Comprehensive Cancer
Network.
https://www.nccn.org/professionals/physician_gls/pdf/squamous.pdf.
Published 2019. Accessed2020.
27. Keohane SG, Proby CM, Newlands C, Motley RJ, Nasr I, Mohd Mustapa
MF. The new 8th edition of TNM staging and its implications for skin
cancer: a review by the British Association of Dermatologists and the
Royal College of Pathologists, U.K. Br J Dermatol.2018;179(4):824-828.
28. Batsakis JG. Surgical excision margins: a pathologist’s perspective.Advances in Anatomic Pathology. 1999;6(3):140-148.
29. O’Brien CJ, McNeil EB, McMahon JD, Pathak I, Lauer CS, Jackson MA.
Significance of clinical stage, extent of surgery, and pathologic
findings in metastatic cutaneous squamous carcinoma of the parotid
gland. . Head Neck. 2012;24(5):417-422.
30. Myers LL, Ahn C. Cutaneous squamous cell carcinoma metastasis to the
parotid region lymph nodes. Laryngoscope 2019;129(7):1579-1586.
31. Košec A, Svetina L, Lukšić I. Significance of clinical stage, extent
of surgery and outcome in cutaneous squamous cell carcinoma of the head
and neck. International Journal of Oral and Maxillofacial
Surgery. 2013;42(1):82-88.
32. Newlands C, Currie R, Memon A, Whitaker S, Woolford T. Non-melanoma
skin cancer: United Kingdom National Multidisciplinary Guidelines.J Laryngol Otol 2016;130(S125-S132).
33. Creighton F, Lin A, Leavitt E, Lin D, Deschler D, Emerick K. Factors
affecting survival and locoregional control in head and neck cSCCA with
nodal metastasis. Laryngoscope 2018;128(8):1881-1886.
34. Bachar G, Mizrachi A, Rabinovics N, et al. Prognostic factors in
metastatic cutaneous squamous cell carcinoma of the head and neck.Ear Nose Throat J. 2016;95(10-11):E32-E36.
35. Coombs AC, Butler A, Allison R. Metastatic cutaneous squamous cell
carcinoma of the parotid gland: prognostic factors. J Laryngol
Otol 2018;132(3):264-269.
36. Skulsky SL, O’Sullivan B, McArdle O, et al. Review of high-risk
features of cutaneous squamous cell carcinoma and discrepancies between
the American Joint Committee on Cancer and NCCN Clinical Practice
Guidelines In Oncology. Head Neck 2017;39(3):578-594.
37. Varra V, Woody NM, Reddy C, et al. Suboptimal Outcomes in Cutaneous
Squamous Cell Cancer of the Head and Neck with Nodal Metastases.Anticancer Res 2018;38(10):5825-5830.
38. Sullivan CB, Andresen NS, Kendell N, Al-Qurayshi Z, Pagedar NA.
Survival Outcomes for Advanced Cutaneous Squamous Cell Carcinoma of the
Head and Neck. Ann Otol Rhinol Laryngol. 2019;128(10):949-955.
39. Sweeny L, Zimmerman T, Carroll WR, Schmalbach CE, Day KE, Rosenthal
EL. Head and neck cutaneous squamous cell carcinoma requiring
parotidectomy: prognostic indicators and treatment selection.Otolaryngol Head Neck Surg. 2014;150(4):610-617.
40. Makki FM, Mendez AI, Taylor SM, et al. Prognostic factors for
metastatic cutaneous squamous cell carcinoma of the parotid. J
Otolaryngol Head Neck Surg. 2013;5(42):14-22.
41. Iyer NG, Clark JR, Murali R, Gao K, O’Brien CJ. Outcomes following
parotidectomy for metastatic squamous cell carcinoma with microscopic
residual disease: implications for facial nerve preservation. Head
Neck 2009;31(1):21-27.
42. O’Brien CJ, McNeil EB, McMahon JD, Pathak I, Lauer CS, Jackson MA.
Significance of clinical stage, extent of surgery, and pathologic
findings in metastatic cutaneous squamous carcinoma of the parotid
gland. Head Neck 2002;24(5):417-422.
43. D’Souza J, Clark J. Management of the neck in metastatic cutaneous
squamous cell carcinoma of the head and neck. Curr Opin
Otolaryngol Head Neck Surg 2011;19(2):99-105.
44. Creighton F, Lin A, Leavitt E, Lin D, Deschler D, Emerick K. Factors
affecting survival and locoregional control in head and neck cSCCA with
nodal metastasis. Laryngoscope. 2018;128(8):1881-1886.
45. Audet N, Palme CE, Gullane PJ, et al. Cutaneous metastatic squamous
cell carcinoma to the parotid gland: analysis and outcome. Head
Neck. 2004;26(8):727-732.
46. Andruchow JL, Veness MJ, Morgan GJ, et al. Implications for clinical
staging of metastatic cutaneous squamous carcinoma of the head and neck
based on a multicenter study of treatment outcomes. Cancer.2006;106(5):1078-1083.
47. Speight PM, Barrett AW. Salivary gland tumor. Oral dis.2002;9:229-240.
48. Palme CE, O’Brien CJ, Venesse CJ, McNeil EB, Bron LP, GJ M. Extent
of Parotid Disease Influences Outcome in Patients With Metastatic
Cutaneous Squamous Cell Carcinoma. Arch Otolaryngol Head Neck
Surg. 2003;129(7):750-753.
49. Skulsky SL, O’Sullivan B, McArdle O, et al. Review of high-risk
features of cutaneous squamous cell carcinoma and discrepancies between
the American Joint Committee on Cancer and NCCN Clinical Practice
Guidelines In Oncology. Head Neck. 2017;39(3):578-594.